All In Biotech

Drug Trial Radar · NCT07121413

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

A Phase IIa, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis

Last checked: Nov 19, 2026Latest source record: Feb 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Nov 4, 2025

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Industry
First posted
Aug 13, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, PK and immunogenicity of SV001 in patients with idiopathic pulmonary fibrosis.

Conditions

  • Idiopathic Pulmonary Fibrosis(IPF)

Interventions

  • SV001Drug

    SV001 : Multiple-dose

  • PlaceboDrug

    Placebo : Multiple-dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse EventsTime frame: Approximately 1 years

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Sichuan Provincial People's Hospital

    Chengdu, China · Recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, China · Recruiting

  • Hangzhou First People's Hospital

    Hangzhou, China · Recruiting

  • The First Affiliated Hospital of Nanchang University

    Nanchang, China · Recruiting

  • Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

    Nanjing, China · Recruiting

  • The Affiliated Hospital of Inner Mongolia Medical University

    Neimeng, China · Recruiting

  • Dongfang Hospital Affiliated to Tongji University

    Shanghai, China · Recruiting

  • Huadong Hospital Affiliated to Fudan University

    Shanghai, China · Recruiting

  • Shanghai Pulmonary Hospital

    Shanghai, China · Recruiting

  • General Hospital of Tianjin Medical University

    Tianjin, China · Recruiting

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, China · Recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.